AVANZ Olive Immunotherapy

· ALK-Abelló A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVANZ Olive Immunotherapy, covering 2013-04-30 to 2013-04-30. Get the full timeline:

Most recent: Clinical Trial Update: An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy [Phase 2, Phase 3]